SK79194A3 - 2-bromine and 2-nitroxy derivatives 3-bromine and 3,3-dibromine-4-oxo-azetidine, method of their preparation and their using - Google Patents

2-bromine and 2-nitroxy derivatives 3-bromine and 3,3-dibromine-4-oxo-azetidine, method of their preparation and their using Download PDF

Info

Publication number: SK79194A3
Authority: SK; Slovakia
Prior art keywords: bromo; hydrogen; bromine; compound according; coor
Prior art date: 1993-07-09

Application number

SK791-94A

Other languages

English (en)

Slovak (sk)

Inventor

Irena Lukic

Original Assignee

Pliva Pharm & Chem Works

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-09

Filing date

1994-06-30

Publication date

1995-04-12

1994-06-30 Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works

1995-04-12 Publication of SK79194A3 publication Critical patent/SK79194A3/sk

Links

238000002360 preparation method Methods 0.000 title claims abstract description 8
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 title claims description 50
229910052794 bromium Inorganic materials 0.000 title claims description 32
238000000034 method Methods 0.000 title abstract description 5
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 72
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 16
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 10
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 8
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 8
239000000203 mixture Substances 0.000 claims abstract description 5
230000000259 anti-tumor effect Effects 0.000 claims abstract description 4
230000002401 inhibitory effect Effects 0.000 claims abstract description 4
229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 4
238000003786 synthesis reaction Methods 0.000 claims abstract description 4
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 4
230000000844 anti-bacterial effect Effects 0.000 claims abstract description 3
238000001704 evaporation Methods 0.000 claims abstract description 3
230000008020 evaporation Effects 0.000 claims abstract description 3
238000009472 formulation Methods 0.000 claims abstract description 3
239000000543 intermediate Substances 0.000 claims abstract description 3
KPADFPAILITQBG-UHFFFAOYSA-N non-4-ene Chemical compound CCCCC=CCCC KPADFPAILITQBG-UHFFFAOYSA-N 0.000 claims abstract description 3
150000003952 β-lactams Chemical class 0.000 claims abstract description 3
239000002904 solvent Substances 0.000 claims abstract 4
229910052739 hydrogen Inorganic materials 0.000 claims description 54
239000001257 hydrogen Substances 0.000 claims description 52
125000001246 bromo group Chemical group Br* 0.000 claims description 44
150000001875 compounds Chemical class 0.000 claims description 35
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 31
-1 benzyl carboxyl Chemical group 0.000 claims description 21
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 17
150000002431 hydrogen Chemical class 0.000 claims description 14
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 claims description 10
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 6
125000006239 protecting group Chemical group 0.000 claims description 6
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
239000000460 chlorine Substances 0.000 claims description 4
229910052801 chlorine Inorganic materials 0.000 claims description 4
230000015572 biosynthetic process Effects 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 3
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 3
JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 3
206010008342 Cervix carcinoma Diseases 0.000 claims description 2
208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
239000012267 brine Substances 0.000 claims description 2
210000004027 cell Anatomy 0.000 claims description 2
201000010881 cervical cancer Diseases 0.000 claims description 2
230000000694 effects Effects 0.000 claims description 2
210000002950 fibroblast Anatomy 0.000 claims description 2
229940041009 monobactams Drugs 0.000 claims description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
125000001309 chloro group Chemical group Cl* 0.000 claims 3
229930189471 penicacid Natural products 0.000 claims 2
239000013543 active substance Substances 0.000 claims 1
125000002619 bicyclic group Chemical group 0.000 claims 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
239000011541 reaction mixture Substances 0.000 abstract description 10
239000000126 substance Substances 0.000 abstract description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 3
238000006243 chemical reaction Methods 0.000 abstract description 3
230000003042 antagnostic effect Effects 0.000 abstract description 2
BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 abstract 2
FMNUBORQHLJREC-UHFFFAOYSA-N (3,3-dibromo-4-oxoazetidin-2-yl) nitrate Chemical compound [O-][N+](=O)OC1NC(=O)C1(Br)Br FMNUBORQHLJREC-UHFFFAOYSA-N 0.000 abstract 1
VVLJZVLXDNESKI-UHFFFAOYSA-N 3,3,4-tribromoazetidin-2-one Chemical compound BrC1NC(=O)C1(Br)Br VVLJZVLXDNESKI-UHFFFAOYSA-N 0.000 abstract 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 abstract 1
239000000376 reactant Substances 0.000 abstract 1
239000000741 silica gel Substances 0.000 abstract 1
229910002027 silica gel Inorganic materials 0.000 abstract 1
DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 abstract 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 25
239000010410 layer Substances 0.000 description 15
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
239000000047 product Substances 0.000 description 8
239000000243 solution Substances 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
239000002253 acid Substances 0.000 description 6
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000003480 eluent Substances 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
TWHRBORGXSAWML-UHFFFAOYSA-N 3,3-dibromoazetidin-2-one Chemical class BrC1(Br)CNC1=O TWHRBORGXSAWML-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
230000002140 halogenating effect Effects 0.000 description 2
229960004592 isopropanol Drugs 0.000 description 2
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
239000007858 starting material Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
DWDDFMFCVGDERN-UHFFFAOYSA-N 1-chloroazetidin-2-one Chemical compound ClN1CCC1=O DWDDFMFCVGDERN-UHFFFAOYSA-N 0.000 description 1
XFRZJXHENYWIEC-UHFFFAOYSA-N 1-methylsulfanylazetidin-2-one Chemical class CSN1CCC1=O XFRZJXHENYWIEC-UHFFFAOYSA-N 0.000 description 1
NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 1
NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
239000000006 Nitroglycerin Substances 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
GUGRBFQNXVKOGR-UHFFFAOYSA-N butyl hypochlorite Chemical group CCCCOCl GUGRBFQNXVKOGR-UHFFFAOYSA-N 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000012043 crude product Substances 0.000 description 1
150000001923 cyclic compounds Chemical class 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
230000010006 flight Effects 0.000 description 1
229960003711 glyceryl trinitrate Drugs 0.000 description 1
JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
CTNZOGJNVIFEBA-MOKAZRKYSA-N isonocardicin A Chemical compound C1=CC(OCC[C@H](N)C(O)=O)=CC=C1C(=N\O)\C(=O)N[C@@H]1C(=O)N([C@@H](C(O)=O)C=2C=CC(O)=CC=2)C1 CTNZOGJNVIFEBA-MOKAZRKYSA-N 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
235000011147 magnesium chloride Nutrition 0.000 description 1
LBHIOVVIQHSOQN-UHFFFAOYSA-N nicorandil Chemical compound [O-][N+](=O)OCCNC(=O)C1=CC=CN=C1 LBHIOVVIQHSOQN-UHFFFAOYSA-N 0.000 description 1
229960002497 nicorandil Drugs 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002994 raw material Substances 0.000 description 1
238000010992 reflux Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
230000009466 transformation Effects 0.000 description 1
150000003751 zinc Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Cephalosporin Compounds (AREA)

SK791-94A 1993-07-09 1994-06-30 2-bromine and 2-nitroxy derivatives 3-bromine and 3,3-dibromine-4-oxo-azetidine, method of their preparation and their using SK79194A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR931047A HRP931047B1 (en)	1993-07-09	1993-07-09	2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and their use

Publications (1)

Publication Number	Publication Date
SK79194A3 true SK79194A3 (en)	1995-04-12

Family

ID=10945991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK791-94A SK79194A3 (en)	1993-07-09	1994-06-30	2-bromine and 2-nitroxy derivatives 3-bromine and 3,3-dibromine-4-oxo-azetidine, method of their preparation and their using

Country Status (16)

Country	Link
US (4)	US5670638A (fr)
EP (1)	EP0633247B1 (fr)
JP (1)	JPH07149716A (fr)
CN (1)	CN1100719A (fr)
AT (1)	ATE166644T1 (fr)
BG (1)	BG61645B1 (fr)
CA (1)	CA2127677C (fr)
CZ (1)	CZ286810B6 (fr)
DE (1)	DE69410539T2 (fr)
ES (1)	ES2118287T3 (fr)
HR (1)	HRP931047B1 (fr)
HU (1)	HUT68298A (fr)
PL (1)	PL178949B1 (fr)
RU (1)	RU2134685C1 (fr)
SI (1)	SI0633247T1 (fr)
SK (1)	SK79194A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK13897A3 (en)	1996-02-06	1998-05-06	Pliva Pharm & Chem Works	3-bromo- and 3,3-dibromo-4-oxo-1-azetidines, method for preparation thereof and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS607635B2 (ja) *	1976-04-27	1985-02-26	塩野義製薬株式会社	オキサゾリジン化合物
DE3169939D1 (en) *	1980-02-28	1985-05-23	Schering Corp	2-penem compounds, pharmaceutical compositions containing them and methods for their preparation
WO1982001705A1 (fr) *	1980-11-13	1982-05-27	Takeda Chemical Industries Ltd	Derives 4-substitue-2-oxoazetidine et leur procede de preparation
JPH03271297A (ja) *	1990-03-22	1991-12-03	Sankyo Co Ltd	白金複核錯体
US5075439A (en) *	1990-08-17	1991-12-24	Pfizer Inc.	Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1-oxo-3-thiolanylthio(thiocarbonyl)thio]azetidin-2-ones and intermediates therefor
HU212573B (en) *	1991-02-12	1996-08-29	Pliva Pharm & Chem Works	Process for producing 4-oxo-azetidine-2-sulfonic acids and their salts

1993
- 1993-07-09 HR HR931047A patent/HRP931047B1/xx not_active IP Right Cessation
1994
- 1994-06-30 SK SK791-94A patent/SK79194A3/sk unknown
- 1994-07-04 SI SI9430165T patent/SI0633247T1/xx unknown
- 1994-07-04 ES ES94110387T patent/ES2118287T3/es not_active Expired - Lifetime
- 1994-07-04 EP EP94110387A patent/EP0633247B1/fr not_active Expired - Lifetime
- 1994-07-04 AT AT94110387T patent/ATE166644T1/de not_active IP Right Cessation
- 1994-07-04 DE DE69410539T patent/DE69410539T2/de not_active Expired - Fee Related
- 1994-07-06 JP JP6154546A patent/JPH07149716A/ja active Pending
- 1994-07-07 CZ CZ19941647A patent/CZ286810B6/cs not_active IP Right Cessation
- 1994-07-08 RU RU94026293A patent/RU2134685C1/ru active
- 1994-07-08 US US08/272,206 patent/US5670638A/en not_active Expired - Fee Related
- 1994-07-08 BG BG98895A patent/BG61645B1/bg unknown
- 1994-07-08 CA CA002127677A patent/CA2127677C/fr not_active Expired - Fee Related
- 1994-07-08 HU HU9402053A patent/HUT68298A/hu unknown
- 1994-07-08 CN CN94108240A patent/CN1100719A/zh active Pending
- 1994-07-08 PL PL94304191A patent/PL178949B1/pl unknown
1995
- 1995-07-10 US US08/500,001 patent/US5637581A/en not_active Expired - Fee Related
1996
- 1996-03-27 US US08/624,919 patent/US5847119A/en not_active Expired - Fee Related
1997
- 1997-09-10 US US08/926,449 patent/US5892036A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE166644T1 (de)	1998-06-15
ES2118287T3 (es)	1998-09-16
CA2127677C (fr)	2000-02-08
EP0633247A1 (fr)	1995-01-11
CN1100719A (zh)	1995-03-29
BG61645B1 (bg)	1998-02-27
US5847119A (en)	1998-12-08
EP0633247B1 (fr)	1998-05-27
CZ164794A3 (en)	1995-07-12
SI0633247T1 (en)	1998-10-31
HU9402053D0 (en)	1994-09-28
PL304191A1 (en)	1995-01-23
RU94026293A (ru)	1996-05-27
US5637581A (en)	1997-06-10
DE69410539T2 (de)	1998-11-26
HRP931047A2 (en)	1997-04-30
CA2127677A1 (fr)	1995-01-10
US5892036A (en)	1999-04-06
RU2134685C1 (ru)	1999-08-20
HRP931047B1 (en)	2000-02-29
HUT68298A (en)	1995-06-28
US5670638A (en)	1997-09-23
PL178949B1 (pl)	2000-07-31
JPH07149716A (ja)	1995-06-13
DE69410539D1 (de)	1998-07-02
CZ286810B6 (en)	2000-07-12
BG98895A (bg)	1995-05-31

Publication	Publication Date	Title
EP3481201B1 (fr)	2020-09-16	Procédés de préparation de 4-alcoxy-3-(acyl ou alkyl)oxypicolinamides
CH651030A5 (fr)	1985-08-30	Polymethylene-4,5 isothiazoline-4 ones-3, le procede de preparation et compositions antibacteriennes, antifongiques ou anti-acne les contenant.
Hall et al.	1984	The 2+ 2 cycloaddition of 4-substituted-1, 2, 4-triazoline-3, 5-diones to diphenylketene
SK79194A3 (en)	1995-04-12	2-bromine and 2-nitroxy derivatives 3-bromine and 3,3-dibromine-4-oxo-azetidine, method of their preparation and their using
US4122086A (en)	1978-10-24	Isopenicillins
Sheehan et al.	1978	Reaction of 6 (7)-diazopenicillanates and diazocephalosporanates with sulfenyl chlorides. Preparation of 6 (7). alpha.-methoxy-substituted thiol penicillanates and thiol cephalosporanates
Sheehan et al.	1977	Derivatives of 6. beta.-methylpenicillanic acid
FR2623502A1 (fr)	1989-05-26	Esters d'acide 3-oxo-1,2,4-triazolo (4,3-a)pyrimidine-6-carboxylique a action therapeutique
EP0210896B1 (fr)	1990-10-10	Dérivés d'acides amino-4 hydroxy-3 carboxyliques optiquement purs et procédé de synthèse stéréospécifique
CA1111856A (fr)	1981-11-03	Derives de l'azetidinone et leur preparation
WO2009112703A1 (fr)	2009-09-17	Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent
Obi et al.	1990	Synthesis of Novel Monobactams Bearing an (R)-1-Hydroxyethyl Group and an (S)-1-Carbamoyl-oxyethyl Group at the C3, 4-Positions
Carpino et al.	1984	Acid-stable, solvolytically deblocked amino-protecting-groups applications of the 1, 3-dibromo-2-methyl-2-propyloxycarbonyl (DB-t-BOC) group
US4889929A (en)	1989-12-26	Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins
BG62565B1 (bg)	2000-02-29	Нови производни на 3-бром- и 3,3-дибром-4-оксо-1-азетидини,метод за тяхното получаване и използването им
Vlietinck et al.	1974	Configuration of phenoxymethyl-and 6-epi phenoxymethylpenicillin sulfoxides
KR820001452B1 (ko)	1982-08-16	페니실란산 유도체의 제조방법
KR790000978B1 (ko)	1979-08-16	아미노 피롤 유도체의 제조방법
BE876466A (fr)	1979-11-23	Derive de l'acide penicillanique et son procede de preparation
KR0139260B1 (ko)	1998-05-15	고리화된 이미다졸을 가지는 벤즈이미다졸 유도체
HRP970713A2 (en)	1999-10-31	7-bromo- and 7,7 dibromo-cepham and cephem derivatives
Kim	1990	SYNTHESIS OF AN AMlNOlSOXAZOLfDlNE SUBSTITUTED QUiNOLONE ACID
SI9700067A (en)	1997-10-31	4-thia-1-azabicyclo /3.2.0./heptane-3-imino-2-isopropylidene-7-oxo analogons of beta-lactams, processes for their preparation and the use thereof
RO114127B1 (ro)	1999-01-29	DERIVAȚI DE 3-BROM Șl 3,3-DIBROM>4-OX0AZETIDII\IE Șl PROCEDEE PENTRU PREPARAREA ACESTORA
ITTO990703A1 (it)	2001-02-09	Procedimento per la preparazione di prodotti intermedi nella sintesidi lisinopril.